Sequence information
DRAVP ID DRAVPc050
Name Adaptavir(Dapta)
Sequence
Molecular Formula C35H56N10O15
Condition/Disease HIV infection
Group Phase Ⅱ clinical trial
Type Peptide
Description Adaptavir is under clinical for the treatment of HIV infection.
Active sequence/Structure
External Links
DrugBank Accession Number DB16290
Pubchem ID 184644
CHEMBL ID CHEMBL181276
UNII J208V4ZMP2
CAS 106362-34-9
ClinicalTrails Information
| NCT Number | Study Title | Condition/Disease | Status | Phase | Sponsor |
|---|---|---|---|---|---|
| NCT00951743 | Safety and Efficacy of ADAPTAVIR's Ability to Eliminate Treatment-Resistant Infectious Virus in Peripheral Blood Mononuclear Cells (PBMCs) | HIV Infections | Unknown | Phase 2 | Rapid Laboratories Inc. |
